Protalix Biotherapeutics Inc (NYSEAMERICAN:PLX) announced its financial results for the nine months ended September 30, 2017 and provided a corporate update. “I am excited …
SNAP continues to frustrate investors after rough 3Q turnout.
Snap Inc (NYSE:SNAP) third-quarter earnings report was another failure on a long, downward path for the social media company as user growth slowed …
Michael Pachter still recognizes upside to the revised lower price target on AMC despite bleak FY:17 outlook.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced its unaudited financial results for the third quarter ended September 30, 2017.
A bull vs. a bear paint a tale of different expectations ahead of Snap’s quarterly performance.
While Priceline’s long-term looks good, short-term faces shake-up.
Is Valeant on track to overcome financial troubles? Mizuho’s Irina Rivkind Koffler remains unconvinced.
Rick Schafer: Data center and gaming momentum will bode well for NVDA’s anticipated quarterly outclass.
Daniel Ives places Snap’s success in ability to magnetize DAU gains and monetize/engage installed base.
